Stock markets mostly rose Thursday on easing trade tensions and some strong company earnings, with London and Frankfurt hitting record highs.

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...

LONDON - Sceptics have long argued that the United Kingdom is past its peak and trading largely on former glories. They point to the country's middli ...

LONDON: European shares hit a record high, gold was near one of its own all-time peaks and bond markets were back under ...

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super Bowl ...

For patients with overweight or obesity and T2D, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes compared with calorie ...

AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

Stock markets rose Thursday on easing trade tensions and some strong company earnings, with London hitting a record high.

AstraZeneca (AZN) stock rises as its Q4 results which exceeded Street forecasts address concerns over its China investigation ...